Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1996
10/01/1996US5561134 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/01/1996US5561110 Administering oligopeptide
10/01/1996US5560936 Intrinsic inhibitors of aldose reductase
10/01/1996CA2173046A1 Process for preparation of benzo¬b|thiophene glucuronides
09/1996
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029337A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications
09/26/1996WO1996029069A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis
09/26/1996WO1996029063A2 Pinitol and derivatives thereof for the treatment of metabolic disorders
09/26/1996CA2216284A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996CA2215731A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis
09/26/1996CA2214635A1 Pinitol and derivatives thereof for the treatment of metabolic disorders
09/25/1996EP0733644A1 Glucagon-like insulinotropic complexes, compositions and methods
09/25/1996EP0733627A1 Thiophene compounds, a method for their preparation and pharmaceutical compositions containing them
09/25/1996EP0733590A1 Salt having more than 99,0% by weight sodium chloride and its use
09/25/1996EP0733103A1 Generation of high titers of recombinant aav vectors
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733061A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents
09/25/1996EP0732942A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
09/25/1996EP0732933A1 Method of treating renal disease by administering igf-i and igfbp-3
09/25/1996EP0732928A1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
09/25/1996EP0732917A1 Nutritional supplement for optimizing cellular health
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996EP0669832B1 Method for treatment or prevention of obesity
09/25/1996EP0569386B1 Bridged cyclic ketal derivatives
09/25/1996CN1131939A Oxidizer carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and antitumor agents
09/25/1996CN1131911A Anthracyclinone derivatives and their use in amyloidosis
09/25/1996CN1131907A Skin patches and methods for providing testosterone
09/25/1996CN1131674A Glucagon insulinotropic complexes, compositions and methods
09/25/1996CN1131666A Tricyclic pyrazole derivatives
09/25/1996CA2171174A1 Salt containing more than 99,0 % per weight of sodium chloride and use thereof
09/24/1996US5559258 Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors
09/24/1996US5559157 Acetate, nicotinate or succinate, sorbic acid preservative
09/24/1996US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
09/24/1996US5559028 Methods of enhancing or antigen presentation to T cells inhibiting
09/24/1996CA2026418C Polypeptides useful as blockers of calcium channels
09/22/1996CA2150080A1 Glucagon-like insulinotropic complexes, compositions and methods
09/19/1996WO1996028548A1 Receptor activation by gas6
09/19/1996WO1996028465A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028464A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028187A1 Method for treating amyloidosis
09/19/1996WO1996028148A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
09/19/1996WO1996028146A1 Novel naphthyl pharmaceutical compounds
09/19/1996CA2215025A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2215022A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2214416A1 Novel naphthyl pharmaceutical compounds
09/18/1996EP0732329A1 Chroman derivative
09/18/1996EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731792A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731791A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731699A1 Method of reducing body fat in animals by the administration of conjugated linoleic acid
09/18/1996EP0531370B1 Inhibition of viral infection
09/18/1996CN1131416A Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
09/18/1996CN1131415A Triaryl-ethylene derivatives for use in therapy
09/18/1996CN1131414A Aminoindanes and related compounds useful as calcium-channel antagonists
09/18/1996CN1131392A Nitric oxide donor composition and method for treatment of anal disorders
09/18/1996CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
09/18/1996CN1131144A Glycinamide derivatives, processes for their preparation and medicines containing them
09/18/1996CN1131038A Xuezhikangtai medicine for curing dyslipoproteinemia and its preparing process
09/18/1996CN1131020A Medicine for reducing blood sugar and its preparation method and use
09/18/1996CN1032787C Synergistic treatment method
09/17/1996US5556876 Anticholesterol agents using derivatives of benzothienyl ketones
09/17/1996US5556870 Use of leflunomide for inhibiting interleukin 1 beta
09/17/1996US5556845 11-β substituted-19-nor steroids
09/17/1996US5556844 Synergistic, skin disorders
09/17/1996US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/17/1996US5556644 Nutritional supplement for the elderly
09/17/1996US5556619 Bile acid sequesterants to lower blood cholesterol, polyamines
09/17/1996CA2021894C Antiparasitic agent
09/12/1996WO1996027662A1 Novel encapsulation process by a gelling polymer
09/12/1996WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/12/1996WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
09/12/1996WO1996027385A1 Anti-obesity proteins
09/12/1996WO1996027367A1 Novel encapsulation compositions and methods
09/12/1996CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996CA2214283A1 Anti-obesity proteins
09/12/1996CA2214088A1 Novel encapsulation process by a gelling polymer
09/12/1996CA2214084A1 Novel encapsulation compositions and methods
09/11/1996EP0731093A1 Naphthyl pharmaceutical compounds
09/11/1996EP0730862A1 Formulation containing glucaric acid for the prevention or treatment of non-cancerous cellular hyperproliferation and dietary supplement
09/11/1996EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
09/11/1996EP0730578A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
09/11/1996EP0730577A1 26,28-methylene-1alpha,25-dihydroxyvitamin d 2 compounds
09/11/1996EP0730571A1 Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors
09/11/1996EP0591252B1 Thiazolidinedione hypoglycemic agents
09/11/1996EP0542952B1 Use of 1-(beta-d-arabinofuranosyl)-5-propynyluracil for lowering serum cholesterol
09/11/1996EP0528950B1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
09/11/1996EP0366710B1 Growth hormone receptor
09/11/1996CN1130874A Method of treating liver disease and like indications with vasodilating agents
09/11/1996CN1130631A Cyclodlkano-indole and-azaindole derivatives
09/11/1996CN1032751C Thiazolidine compound, preparing process thereof and its application in medicine
09/11/1996CN1032750C Process for prepn. of ureido derivatives of poly 4-amino-2-carboxy-1-methyl compounds
09/10/1996US5554755 Acylation
09/10/1996US5554646 Method for reducing body fat in animals
09/10/1996US5554643 Pro-drugs for CCK antagonists
09/10/1996US5554642 Arylalkyl(thio) amides
1 ... 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 ... 1298